Worthy of mention, this spring, a U.S
Treating obesity with personalized cognitive behavioral therapy
DOI: 10.1007/s00018-024-05507-6 [Google Scholar] Marso SP, Daniels GH, Brown-Frandsen K, Kristensen P, Mann JF, Nauck MA, et al
Both Ozempic and Wegovy are part of a class of drugs called GLP-1 Receptor Agonists that help people produce insulin to lower the amount of sugar in their blood
Her expertise comes from working with leading doctors and health experts, staying up to date on the latest research on supplements, testing new products and crafting easy-to-understand guides
Comprehensive Obesity Management Programs Pairing GLP-1 therapy with behavioral interventions and structured weight management programs improves long-term success and reduces reliance on medication